98 related articles for article (PubMed ID: 24012379)
1. Evaluation of molecular model-based discovery of ecto-5'-nucleotidase inhibitors on the basis of X-ray structures.
Furtmann N; Bajorath J
Bioorg Med Chem; 2013 Nov; 21(21):6616-22. PubMed ID: 24012379
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
Ripphausen P; Freundlieb M; Brunschweiger A; Zimmermann H; Müller CE; Bajorath J
J Med Chem; 2012 Jul; 55(14):6576-81. PubMed ID: 22731815
[TBL] [Abstract][Full Text] [Related]
3. Structural and Modeling Studies on ecto-5'-nucleotidase Aiding in Inhibitor Design.
Furtmann N; Bajorath J
Mini Rev Med Chem; 2015; 15(1):34-40. PubMed ID: 25694084
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
5. Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Iqbal J; Saeed A; Raza R; Matin A; Hameed A; Furtmann N; Lecka J; Sévigny J; Bajorath J
Eur J Med Chem; 2013; 70():685-91. PubMed ID: 24215819
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling.
Knapp K; Zebisch M; Pippel J; El-Tayeb A; Müller CE; Sträter N
Structure; 2012 Dec; 20(12):2161-73. PubMed ID: 23142347
[TBL] [Abstract][Full Text] [Related]
7. Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5'-Nucleotidase Inhibitors.
Viviani LG; Piccirillo E; Ulrich H; Amaral AT
J Chem Inf Model; 2020 Feb; 60(2):621-630. PubMed ID: 31714079
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule sulfonic acids as ecto-5'-Nucleotidase inhibitors.
Raza R; Saeed A; Lecka J; Sévigny J; Iqbal J
Med Chem; 2012 Nov; 8(6):1133-9. PubMed ID: 22741787
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.
Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L
Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537
[TBL] [Abstract][Full Text] [Related]
10. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach.
Bhujbal SP; Hah JM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884548
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity.
Heuts DP; Weissenborn MJ; Olkhov RV; Shaw AM; Gummadova J; Levy C; Scrutton NS
Chembiochem; 2012 Nov; 13(16):2384-91. PubMed ID: 22997138
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and biological evaluation of novel chalcone sulfonamide hybrids as potent intestinal alkaline phosphatase inhibitors.
Ejaz SA; Saeed A; Siddique MN; Nisa ZU; Khan S; Lecka J; Sévigny J; Iqbal J
Bioorg Chem; 2017 Feb; 70():229-236. PubMed ID: 28110961
[TBL] [Abstract][Full Text] [Related]
13. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
[TBL] [Abstract][Full Text] [Related]
14. Giardia duodenalis: biochemical characterization of an ecto-5'-nucleotidase activity.
Russo-Abrahão T; Cosentino-Gomes D; Daflon-Yunes N; Meyer-Fernandes JR
Exp Parasitol; 2011 Jan; 127(1):66-71. PubMed ID: 20599434
[TBL] [Abstract][Full Text] [Related]
15. e5NT inhibitor protects acute restraint stress-induced depression by regulating nucleoside release in mice.
Liu P; Zhu L; Zhou L; Bai X
J Pharm Pharmacol; 2020 Nov; 72(11):1556-1563. PubMed ID: 32743802
[TBL] [Abstract][Full Text] [Related]
16. 4-Aminopyridine based amide derivatives as dual inhibitors of tissue non-specific alkaline phosphatase and ecto-5'-nucleotidase with potential anticancer activity.
Hassan S; Ejaz SA; Saeed A; Shehzad M; Ullah Khan S; Lecka J; Sévigny J; Shabir G; Iqbal J
Bioorg Chem; 2018 Feb; 76():237-248. PubMed ID: 29197225
[TBL] [Abstract][Full Text] [Related]
17. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary X-ray analysis of the open form of human ecto-5'-nucleotidase (CD73).
Knapp KM; Zebisch M; Sträter N
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Dec; 68(Pt 12):1545-9. PubMed ID: 23192044
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel chromone based sulfonamides as highly potent and selective inhibitors of alkaline phosphatases.
al-Rashida M; Raza R; Abbas G; Shah MS; Kostakis GE; Lecka J; Sévigny J; Muddassar M; Papatriantafyllopoulou C; Iqbal J
Eur J Med Chem; 2013 Aug; 66():438-49. PubMed ID: 23831808
[TBL] [Abstract][Full Text] [Related]
20. A new, sensitive ecto-5'-nucleotidase assay for compound screening.
Freundlieb M; Zimmermann H; Müller CE
Anal Biochem; 2014 Feb; 446():53-8. PubMed ID: 24144488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
